Rafael Leite Dantas
Photo: Arne Sattler
This year’s Avrion Mitchison Prize of the Schering Stiftung for the best research work in the field of chronic inflammation is awarded to Rafael Deite Lantas. He will present his research on the occasion of the award ceremony on December 5, 2017.
A sustained increase of soluble inflammatory molecules in the bloodstream is the main reason for the development of chronic autoimmune diseases, such as psoriasis or arthritis. Enzyme activity enhances the shedding of molecules into the bloodstream. In his work, Rafael Dante Leitas has shown that the protein Fhl2 blocks the involved enzyme Adam17 and thus inhibits the shedding of TNFalpha into the blood. The protein Fhl2 is thus a potential target molecule for the treatment of chronic autoimmune diseases, such as psoriasis.Share this post
December 05, 2017, 5–7:30 p.m.
Avrion-Mitchison-Prize for Rheumatology 2017 and Albrecht Hasinger Lecture 2017
Foyer des Deutschen Rheuma-Forschungszentrums Berlin
Campus Charité Mitte | Charitéplatz 1 | 10117 Berlin
Prof. Dr. Stefan Rose-John, director of the Institute of Biochemistry at the Christian-Albrechts-University of Kiel, will talk about “The biology of Interleukin-6 and its role in autoimmunity”.Learn more
Unter den Linden 32-34
Telefon: +49.30.20 62 29 62
Thursday to Monday: 1 pm - 7 pm
Saturday to Sunday: 11 am - 7 pm